Matches in Wikidata for { <http://www.wikidata.org/entity/Q66026099> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q66026099 description "clinical trial" @default.
- Q66026099 description "ensayu clínicu" @default.
- Q66026099 description "klinisch onderzoek" @default.
- Q66026099 description "клінічне випробування" @default.
- Q66026099 name "Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants" @default.
- Q66026099 name "Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants" @default.
- Q66026099 type Item @default.
- Q66026099 label "Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants" @default.
- Q66026099 label "Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants" @default.
- Q66026099 prefLabel "Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants" @default.
- Q66026099 prefLabel "Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants" @default.
- Q66026099 P1050 Q66026099-58EC1E3E-1405-4502-9288-071407E30E87 @default.
- Q66026099 P1132 Q66026099-929E7F53-3CC8-430B-8B1F-B20C6798ED54 @default.
- Q66026099 P1476 Q66026099-268030A2-2A4B-4F19-A09A-419E25C5825D @default.
- Q66026099 P17 Q66026099-364080CB-7B0C-4347-B245-41261A4669BD @default.
- Q66026099 P3098 Q66026099-2B874F74-8967-485B-B80D-6DBBF46B3FCA @default.
- Q66026099 P31 Q66026099-62F4F6A4-D2E6-49DF-8616-EC02F45B026B @default.
- Q66026099 P580 Q66026099-D55E548E-34E6-41AD-A9CE-53D4CADDB258 @default.
- Q66026099 P582 Q66026099-5D17BCBC-0596-4444-A9EE-D34F1467A185 @default.
- Q66026099 P6099 Q66026099-B0997B04-2FBF-4973-8C36-336C7EC8343B @default.
- Q66026099 P6153 Q66026099-2DD67171-5DD2-4D48-A5E7-8F1EF7F6F3B4 @default.
- Q66026099 P8363 Q66026099-08838EBF-AAD0-41E0-A5F4-FD9B750E291B @default.
- Q66026099 P859 Q66026099-A2A00D54-0EBF-4A0A-99FD-4BA5D43C1B78 @default.
- Q66026099 P1050 Q156103 @default.
- Q66026099 P1132 "+450" @default.
- Q66026099 P1476 "A Phase IIIb, Partially Blind, Randomized, Placebo-controlled Study to Asses the Effect on Immunogenicity of Administration of Vaccine Without Buffering Agent and to Assess Heat Stability in Terms of Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Following a 0, 2 Month Schedule, in Healthy Infants Previously Uninfected With Human Rotavirus" @default.
- Q66026099 P17 Q869 @default.
- Q66026099 P3098 "NCT00169455" @default.
- Q66026099 P31 Q30612 @default.
- Q66026099 P580 "2005-03-01T00:00:00Z" @default.
- Q66026099 P582 "2005-12-01T00:00:00Z" @default.
- Q66026099 P6099 Q42824827 @default.
- Q66026099 P6153 Q212322 @default.
- Q66026099 P8363 Q78089383 @default.
- Q66026099 P859 Q212322 @default.